RxDoctor Payments Data

Sasan Roayaie, MD

Surgery · New York, NYNPI 1669448445

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $13,600 of the $14,829 with a category attached, or 91.7%. 4 manufacturers reported payments, led by Medtronic at 55.7% of the total. Reporting peaked in 2021 at $8,000 and has fallen 99.7% since, to $23 in 2025.

$14,829in general payments, 2019–2025

Across 12 payments — averaging $1235.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Covidien LP$6K
  • Cook Medical LLC$172
  • Kerecis Limited$23
$358,570in research payments, 2019–2025

Across 9 payments — averaging $39,841 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$324K
  • Astrazeneca UK Limited$34K

What the payments were for

  • Speaking & faculty fees$13,60092%
  • Travel & lodging$7595%
  • Food & beverage$4703%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic6$8,267
Covidien LP4$6,367
Cook Medical LLC1$172
Kerecis Limited1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,829 in reported general payments places this provider in the 85th percentile of 1,596 surgery providers in New York.

See all surgery providers in New York

Medicare billing

Part B allowed, 2024
$193,785
Medicare patients
211
Services billed
589

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →